Eric Topol: Frustrated that doctors are slow to adopt pharmacogenomics
Dr. Eric Topol is frustrated. There’s been a series of genomic discoveries that tell us how individuals tolerate common drugs. But physicians, for the most part, still aren’t applying this in...
View ArticleThis week on MedHeads: News from #BIO2015 and the Health Innovation Summit
This week, Neil Versel and Meghana Keshavan join Stephanie Baum to recap the Health Innovation and BIO International Conventions they attended, such as the convergence of digital health and drug...
View ArticlePrecision Medicine: 8 must-follow Twitter users (updated)
#PrecisionMedicine is barreling to the forefront of healthcare these days . It’s hard to keep up with the endless stream of updates, but Twitter’s a good tool to keep up with the news. Many of you are...
View ArticleIs your chemotherapy working? This simple test could tell you
A cluster of breast cancer cells undergoing apoptosis, or cell death. It’s still largely trial and error to determine the efficacy of cancer treatment – there isn’t any one test that can determine...
View ArticleTopol: Apple Watch helps colleague’s patient self-diagnose heart condition
Dr. Eric Topol, chief academic officer of Scripps Health in San Diego and director of the Scripps Translational Research Institute, is creating yet another buzz on Twitter with this post about...
View ArticleEric Topol wears genetic data on his sleeve to promote carrier screening
Eric Topol just found out he carries the recessive alleles for two serious genetic diseases: A metabolic muscle disease called myoadenylate deaminase deficiency, and hereditary hemochromatosis – a...
View ArticleMD Connect lists physicians on Twitter; Here are some more in health IT
We love lists, for better or for worse. Last week, Jonathan Catley of online healthcare marketing firm MD Connect came up with list of “20 doctors you should be following on Twitter.” It’s a pretty...
View ArticleTopol talks digital health with CNBC’s Jim Cramer (video)
Dr. Eric Topol (left) with “Mad Money” host Jim Cramer Dr. Eric Topol is back in the spotlight. Tuesday evening, the chief academic officer of Scripps Health in San Diego, director of the Scripps...
View Article‘Moneyball’ meets medicine: DePodesta joins Topol at Scripps
Dr. Eric Topol (left) walks with Paul DePodesta outside the Scripps Translational Research Center in La Jolla, California. This time, “Moneyball” meets medicine for real. Major League Baseball...
View ArticleLife Science Limericks: 2015 Edition
The life sciences biz had a colorful year. We were on the sidelines of scandal (Shkreli), disillusionment (Theranos) and some extreme M&A. As such, the internet’s awash with year-end highlight...
View ArticleHealth data should belong to patients, Topol argues
The digital revolution’s merging of medicine with high tech has unleashed massive amounts of data about the most intimate details of our life — what we ate, how far we walked, how fast our heart beat....
View ArticleTopol calls patient data ownership a future civil right
“I don’t see Epic, Allscripts or Cerner in existence in another decade,” Topol said.
View ArticleWhat Mark Zuckerberg told Dr. Eric Topol about his interest in healthcare
Dr. Eric Topol, the digital health evangelist and cardiologist at Scripps, offers a tantalizing look into what the Silicon Valley entrepreneur and medical philanthropist, cares about in healthcare.
View ArticleThis week in patient engagement: Topol fights pain, a nurse learns empathy
Evidence-based medicine didn’t work for Dr. Eric Topol when he had complications after a knee replacement, so he started experimenting. Meanwhile, an oncology nurse apologized to her patients for not...
View ArticleHealthSparq seeks ‘idiotic’ stories with #WhatTheHealthCare campaign
The campaign’s business objective is to put HealthSparq at the forefront of the patient engagement discussion and provide “a brand lift,” said Burt Rosen, vice president and chief marketing officer for...
View ArticleLiving in the moment: Point-of-care market tops $18B
The point-of-care transformation is well underway as healthcare and tech companies dive into a market now worth over $18 billion a year.
View ArticleWill the Neil deGrasse Tyson of medicine please stand up?
There are many inspirational names in modern-day healthcare and, partially due to reform, room for […]
View ArticleActivism, art and the future of patient empowerment: Q&A with Regina Holliday
Regina Holliday is a well-known patient advocate, activist and artist. A widow and mother, she […]
View ArticleTopol, Scripps cardiologists on moving beyond the mHealth hype
What does mobile health need more than anything right now? Real-world clinical evidence that demonstrates […]
View ArticleSix smart takes on the 23andMe FDA standoff
Here are a few long reads beyond just where the FDA warning letter told genetic […]
View Article